about
Preliminary results of the Spanish Association of Urology National Registry in Active Surveillance for prostate cancer.Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.Genetic predisposition to early recurrence in clinically localized prostate cancer.Comparison of fetal weight distribution improved by paternal height by Spanish standard versus Intergrowth 21st standard.Maternal morbidity after implementation of a postpartum hemorrhage protocol including use of misoprostol.The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry.Urology and Web predictive resources.A Preliminary Study of the Ability of the 4Kscore test, the Prostate Cancer Prevention Trial-Risk Calculator and the European Research Screening Prostate-Risk Calculator for Predicting High-Grade Prostate Cancer.Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.Variability in the multicentre National Registry in Active Surveillance; a questionnaire for urologistsRole of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillanceImplementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancerValidation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening populationHow to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsiesClinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysisAre targeted prostate biopsies ready to replace systematic prostate biopsies?Pregestational body mass index, trimester-specific weight gain and total gestational weight gain: how do they influence perinatal outcomes?Detection of Adverse Perinatal Outcomes at Term Delivery Using Ultrasound Estimated Percentile Weight at 35 Weeks of Gestation: Comparison of Five Fetal Growth Standards
P50
Q30376103-5805EC3B-89FD-4BF3-9248-08BC9C3EECF8Q35771276-CDDC1FC2-F556-498D-83B1-6DD3D95BE6A8Q46304406-AEE73147-2EC2-4A90-9BC2-468598F9792BQ47213856-8973EE92-9417-4A34-8D26-CDD723B7CDE5Q47412869-0247B383-742E-4FA1-8545-A6FBC5E22020Q47444078-BE05435A-8926-4F34-B97B-C5062AAFFD32Q49016342-02593F30-E83D-4D06-86C2-5B78E96D9E8FQ50276235-D34F44B5-4414-40D2-9638-B0A51B295CA9Q51904524-930B710F-1830-49EE-9ED7-C6A6B9BF548EQ56516064-EDCF8070-B7A9-4FE6-BE86-F1D83AEEA578Q57107930-DE9E928F-9760-4504-A322-3D65D7E02314Q87294913-C03EFE3F-0477-400C-BE79-2CD77547DB00Q89797894-13A560BC-433B-4368-9E68-FCB26AB8C86EQ90046425-A21D2761-61D9-4558-B451-0101FAB00DC8Q90280050-ACFF7335-DDBE-401D-A5F6-5DEB7268E3D0Q91076957-44F3CF04-4C26-42B2-B747-EB65BC6E8F75Q92566515-2F14E2AD-F85D-41CC-9DFD-B43497D9EE4CQ92850758-200C1F0C-444D-4534-B1E5-D0C71F113DFA
P50
description
researcher ORCID ID = 0000-0002-3007-302X
@en
wetenschapper
@nl
name
Luis M Esteban
@ast
Luis M Esteban
@en
Luis M Esteban
@nl
type
label
Luis M Esteban
@ast
Luis M Esteban
@en
Luis M Esteban
@nl
prefLabel
Luis M Esteban
@ast
Luis M Esteban
@en
Luis M Esteban
@nl
P21
P31
P496
0000-0002-3007-302X